LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Lazard Capital Markets Fourth Annual Healthcare Conference on Tuesday, November 27, 2007 at 11:00 am (ET) at New York Palace Hotel. A live audio webcast and replay of the presentation will be available on the “Investors” section of the Company’s website, www.syntapharma.com.